1107 studies found for:    Ovarian Cancer: Clinical Trials
Show Display Options
RSS Create an RSS feed from your search for:
Ovarian Cancer: Clinical Trials
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor
Conditions: Platinum Refractory Epithelial Ovarian Cancer;   Primary Cancer of the Peritoneum;   Cancer of the Fallopian Tube
Interventions: Drug: Sunitinib;   Drug: SUNITINIB
2 Active, not recruiting Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: decitabine
3 Active, not recruiting Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)
Conditions: Ovarian Epithelial Cancer;   Ovarian Germ Cell Tumor
Interventions: Other: cytology specimen collection procedure;   Procedure: ultrasound imaging;   Other: screening questionnaire administration
4 Active, not recruiting Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Other: Early detection
5 Active, not recruiting Clinical Trial Investigating Pazopanib in Patients With Platinum-resistant Advanced Ovarian Cancer
Condition: Platinum-resistant Advanced Ovarian Cancer
Intervention: Drug: Pazopanib
6 Completed
Has Results
Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma
Conditions: Ovarian Carcinoma;   Peritoneal Neoplasms
Intervention: Drug: Docetaxel and Gemcitabine
7 Withdrawn Economic Outcomes in Patients With Stage III Ovarian Cancer Receiving Paclitaxel and Cisplatin on Clinical Trial GOG-172
Condition: Ovarian Cancer
Intervention: Procedure: quality-of-life assessment
8 Active, not recruiting Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer;   Fallopian Cancer;   Peritoneal Cancer
Interventions: Biological: E39 peptide vaccine;   Other: Clinical tracking for disease progression/recurrence
9 Completed Assess Cancer in Ovarian Tumors With Biomarkers.
Condition: Ovarian Tumor
Intervention: Procedure: Blood Draw
10 Recruiting Trial of Adjuvant FANG™ Vaccine for High Risk Stage III/IV Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Biological: FANG™
11 Unknown  An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: cediranib
12 Unknown  Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical Trial
Condition: Ovarian Neoplasms
Intervention: Procedure: neoadjuvant chemotherapy (Carboplatin/Docetaxel)
13 Recruiting EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Paclitaxel + Carboplatin every 3 weeks;   Drug: Carboplatin monotherapy every 3 weeks;   Drug: Weekly Paclitaxel and Carboplatin
14 Unknown  Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA)
Conditions: Cancer.;   Melanoma.;   Ovarian Cancer.;   Lung Cancer.
Interventions: Biological: NY-ESO-1 combined with MPLA;   Biological: NY-ESO-1 combined with MPLA vaccine
15 Recruiting Orteronel (TAK-700) in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors. The Greko II Study.
Condition: Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors
Intervention: Drug: Orteronel 300mg BID
16 Terminated Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction
Conditions: Ovarian Cancer;   Peritoneal Cancer;   Fallopian Tube Cancer;   Bowel Obstruction
Interventions: Drug: Cisplatin;   Drug: Paclitaxel
17 Completed A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: ABT-888;   Drug: pegylated liposomal doxorubicin;   Drug: temozolomide
18 Completed Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
Conditions: Brain and Central Nervous System Tumors;   Childhood Germ Cell Tumor;   Extragonadal Germ Cell Tumor;   Leukemia;   Liver Cancer;   Lymphoma;   Neuroblastoma;   Ovarian Cancer;   Psychosocial Effects of Cancer and Its Treatment;   Sarcoma;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Procedure: psychosocial assessment and care
19 Terminated Clinical Trial for Ovarian Cancer (OvaRex®)
Condition: Ovarian Cancer
Intervention: Drug: oregovomab
20 Recruiting ICON8: Weekly Chemotherapy in Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Carboplatin;   Drug: Paclitaxel

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years